Vicplas International (SGX:569) EBIT : S$3.6 Mil (TTM As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Vicplas International EBIT?

Vicplas International's earnings before interest and taxes (EBIT) for the six months ended in Jan. 2024 was S$0.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2024 was S$3.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Vicplas International's annualized ROC % for the quarter that ended in Jan. 2024 was -2.06%. Vicplas International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 1.76%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Vicplas International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 4.23%.

Vicplas International EBIT Historical Data

The historical data trend for Vicplas International's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International EBIT Chart

Vicplas International Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

EBIT

Get a 7-Day Free Trial

4.32

7.78

12.83

11.86

6.77

Vicplas International Semi-Annual Data
	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24
EBIT	Get a 7-Day Free Trial															6.30	5.56	3.87	2.90	0.69

Competitive Comparison of Vicplas International's EBIT

For the Medical Devices subindustry, Vicplas International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vicplas International's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Vicplas International's EV-to-EBIT falls into.

Vicplas International EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$3.6 Mil.

Vicplas International (SGX:569) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Vicplas International's annualized ROC % for the quarter that ended in Jan. 2024 is calculated as:

	ROC % (Q: Jan. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jul. 2023 )	+	Invested Capital (Q: Jan. 2024 ))	/ count )
=	-2.516 * ( 1 - 19.13% )	/	( (91.344	+	106.4)	/ 2 )
=	-2.0346892	/	98.872
=	-2.06 %

where

	Invested Capital		(Q: Jul. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	119.021	-	19.111	-	( 8.566	-	max(0, 27.251	-	69.409	+	8.566	))
=	91.344

	Invested Capital		(Q: Jan. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	126.646	-	15.786	-	( 4.46	-	max(0, 31.245	-	66.928	+	4.46	))
=	106.4

Note: The Operating Income data used here is two times the semi-annual (Jan. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Vicplas International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jan. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jul. 2023		Q: Jan. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	1.378	/	( ( (46.096 + max(26.899, 0))	+	(56.256 + max(27.065, 0)) )	/	2 )
=	1.378	/	( ( 72.995	+	83.321 )	/	2 )
=	1.378	/	78.158
=	1.76 %

where Working Capital is:

	Working Capital		(Q: Jul. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(24.875	+	19.342	+	2.259)	-	(19.111	+	0	+	0.466)
=	26.899

	Working Capital		(Q: Jan. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(26.835	+	15.917	+	0.53999999999999)	-	(15.786	+	0	+	0.441)
=	27.065

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jan. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Vicplas International's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jan. 2024 )
	=	3.585	/	84.829
	=	4.23 %

Vicplas International EBIT Related Terms

Thank you for viewing the detailed overview of Vicplas International's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicplas International (SGX:569) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

35 Joo Koon Circle, Singapore, SGP, 629110

Website

https://www.vicplas.com

Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines